okredo logo
none title certification

Baryon Pharmaceuticals UAB Finance - revenue, profit

eye icon
More information

EBITDA margin (%)

unlock data icon

Register and

explore Okredo data
More information

EBIT margin (%)

unlock data icon

Register and

explore Okredo data

EBITDA margin (%)

Login to see the data

EBIT margin (%)

Login to see the data

Financial statetment report

Price: €9.90
Premium users: 1.00 credit
Indicator
Turnover (€)
Sales per employee (€)info
Profit before tax (€)
Net Profit (€)
Profit per employee (€)info
Working capital requirementinfo
Debt-to-equity ratioinfo
Total profitability (%)info
Net profitability (%)info
Equity (€)
Amounts Payable And Liabilities (€)
Non-current Assets (€)
CurrentAssets (€)
EBITDA margin (%)info
EBITDA (€)info
EBIT margin (%)info
EBIT (€)info
2021
0
-
0
0
-
-
0.00
-
-
2,500
0
0
2,500
2022
0
0
62,556
-62,556
-41,984
-
-1.10
-
-
-60,056
66,014
0
5,958
2023
73,963
43,253
47,686
-47,686
-27,887
-0.29
-2.71
-52.46
-64.47
-21,708
58,830
0
37,122
unlock data icon

Register and

explore Okredo data
2023
73,963
43,253
47,686
-47,686
-27,887
-0.29
-2.71
-52.46
-64.47
-21,708
58,830
0
37,122
unlock data icon

Register and

explore Okredo data

2023

Turnover (€)

73,963 €Ascended- *

Sales per employee (€)

43,253 €Ascended- *

Profit before tax (€)

47,686 €Descended-24 % *

Net Profit (€)

-47,686 €Ascended24 % *

Profit per employee (€)

-27,887 €Ascended34 % *

Working capital requirement

-0.29 Ascended- *

Debt-to-equity ratio

-2.71 Descended-146.36 % *

Total profitability (%)

-52.46 %Ascended- *

Net profitability (%)

-64.47 %Ascended- *

Equity (€)

-21,708 €Ascended64 % *

Amounts Payable And Liabilities (€)

58,830 €Descended-11 % *

Non-current Assets (€)

0 €Ascended- *

CurrentAssets (€)

37,122 €Ascended523 % *

*over the last year starting selected period